Eric Omdahl

Eric Omdahl is a seasoned quality control professional with extensive experience in the biopharmaceutical industry. Currently serving as Senior Manager of Quality Control at BioFactura, Inc., Eric plays a pivotal role in the organization’s Quality leadership team, focusing on the qualification and validation of methods for GMP release of monoclonal antibodies and protein biologics. Prior experience includes significant contributions at Novavax, where Eric supervised quality control for critical reagents during the development of the NVX-CoV2373 vaccine and managed a critical reagent program essential for batch release processes. With a foundation in scientific expertise from roles at Catalent Pharma Solutions, Meso Scale Diagnostics, and Charles River Laboratories, coupled with advanced degrees in Biotechnology and Regulatory Affairs from Johns Hopkins University and a Bachelor's in Biology from the University of Maryland, Eric Omdahl demonstrates a strong commitment to quality assurance and regulatory compliance in biotechnology.